Thirty-day outcomes of a novel transcatheter heart valve to treat degenerated surgical valves: the VIVALL multicentre, single-arm, pilot study
Ulrich Schäfer(Universität Hamburg), Lenard Conradi, Tobias Schmidt(Asklepios Fachklinikum Brandenburg), Christian Frerker(University Hospital Schleswig-Holstein), Martin Landt, Hendrik Treede(Universität Hamburg), Johannes Schirmer(Universität Hamburg), Abdelhakim Allali(Segeberger Kliniken), Efstratios I. Charitos(University of Bonn), Christian Butter(University of Zurich), Cornel Koban
Cited by 15
Related Papers
Efficacy of telemedical interventional management in patients with heart failure (TIM-HF2): a randomised, controlled, parallel-group, unmasked trial
|The Lancet|2018|734
Effect of Resynchronization Therapy Stimulation Site on the Systolic Function of Heart Failure Patients
|Circulation|2001|626
Outcomes in Transcatheter Aortic Valve Replacement for Bicuspid Versus Tricuspid Aortic Valve Stenosis
|Journal of the American College of Cardiology|2017|486
Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification
|European Heart Journal|2018|377
Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation
|Journal of the American College of Cardiology|2017|331